As filed with the U.S. Securities and Exchange Commission on February 25, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
Enovix Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 85-3174357 | ||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
3501 W. Warren Avenue
Fremont, CA 94538
(Address of principal executive offices, including zip code)
Fremont, CA 94538
(Address of principal executive offices, including zip code)
Enovix Corporation 2021 Equity Incentive Plan
Enovix Corporation 2021 Employee Stock Purchase Plan
(Full titles of the plans)
Arthi Chakravarthy
Chief Legal Officer
Enovix Corporation
3501 W. Warren Avenue
Fremont, CA 94538
Telephone: (510) 695-2350
(Name, address and telephone number, including area code, of agent for service)
Copies to:
| Michael Penney | ||
| Arnold & Porter Kaye Scholer LLP | ||
| 250 West 55th Street | ||
New York, NY 10019 | ||
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer x | Accelerated filer ¨ | ||||
Non-accelerated filer ¨ | Smaller reporting company ¨ | ||||
Emerging growth company ¨ | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
EXPLANATORY NOTE
Enovix Corporation (the “Registrant”) is filing this Registration Statement for the purpose of registering (i) an additional 7,622,538 shares of the Registrant’s common stock, par value $0.0001 per share (“Common Stock”), to be issued pursuant to the Registrant’s 2021 Equity Incentive Plan (the “2021 Plan”) and (ii) an additional 1,905,634 shares of Common Stock to be issued pursuant to the Registrant’s 2021 Employee Stock Purchase Plan (the “2021 ESPP”). The shares of Common Stock being registered pursuant to this Registration Statement are the same class as, and in addition to, other securities for which the Registration Statements on Form S-8 were filed with the Securities and Exchange Commission (the “SEC”) on September 23, 2021 (File No. 333-259730), August 24, 2022 (File No. 333-267050), August 9, 2023 (File 333-273847), and August 5, 2024 (File 333-281261) (collectively, the “Prior Registration Statements”). Pursuant to General Instruction E to Form S-8, the contents of the Prior Registration Statements, to the extent relating to the registration of Common Stock issuable under the 2021 Plan and the 2021 ESPP, are incorporated herein by reference and made part of this Registration Statement, except as amended hereby.
PART II
ITEM 3. INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The Registrant is incorporating by reference into this Registration Statement the filings listed below and any additional documents that the Registrant may file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), after the date of this Registration Statement, but prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, except the Registrant is not incorporating by reference any information that is not deemed to be “filed” under Section 18 of the Exchange Act or otherwise subject to the liabilities of that section (including documents or information deemed furnished pursuant to Item 2.02 or Item 7.01 of any Current Report on Form 8-K and corresponding information furnished under Item 9.01 as an exhibit thereto), unless the report or filing containing such information indicates that the information is to be considered “filed” under the Exchange Act or is to be incorporated by reference in this Registration Statement:
(a) the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 29, 2024 filed with the SEC on February 25, 2025;
(b) the Registrant’s Current Report on Form 8-K filed with the SEC on January 6, 2025; and
(c) the description of the Registrant’s Common Stock that is contained in Exhibit 4.4 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended January 2, 2022, including any amendment or supplements thereto.
Any statement contained in this Registration Statement, or in a document incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded to the extent that a statement contained herein, or in any subsequently filed document that also is incorporated or deemed to be incorporated by reference herein, modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
1
ITEM 8. EXHIBITS
| Incorporated by Reference | |||||||||||||||||
Exhibit Number | Exhibit Description | Form | File No. | Exhibit | Filing Date | ||||||||||||
| 4.1 | 8-K | 001-39753 | 3.1 | July 19, 2021 | |||||||||||||
| 4.2 | 8-K | 001-39753 | 3.2 | July 19, 2021 | |||||||||||||
| 4.3 | S-4/A | 333-253976 | 4.5 | June 21, 2021 | |||||||||||||
| 5.1* | |||||||||||||||||
| 23.1* | |||||||||||||||||
| 23.2* | |||||||||||||||||
| 24.1* | |||||||||||||||||
| 99.1 | 8-K | 001-39753 | 10.2 | July 19, 2021 | |||||||||||||
| 99.2 | S-4/A | 333-253976 | 10.11 | June 21, 2021 | |||||||||||||
| 99.3 | S-4/A | 333-253976 | 10.12 | June 21, 2021 | |||||||||||||
| 99.4 | 10-Q | 001-39753 | 10.1 | August 16, 2022 | |||||||||||||
| 99.5 | 10-Q | 001-39753 | 10.7 | May 5, 2023 | |||||||||||||
| 99.6 | 8-K | 001-39753 | 10.5 | July 19, 2021 | |||||||||||||
| 99.7 | 10-Q | 001-39753 | 10.2 | May 7, 2024 | |||||||||||||
| 107* | |||||||||||||||||
* Filed herewith.
3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fremont, State of California, on this 25th day of February, 2025.
| ENOVIX CORPORATION | |||||||||||
| By: | /s/ Raj Talluri | ||||||||||
Dr. Raj Talluri | |||||||||||
| President and Chief Executive Officer | |||||||||||
4
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. Raj Talluri and Kristina Truong, and each of them, as their true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for them and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||
/s/ Raj Talluri | President and Chief Executive Officer and Director (Principal Executive and Financial Officer) | February 25, 2025 | ||||||
Dr. Raj Talluri | ||||||||
| /s/ Kristina Truong | Chief Accounting Officer (Principal Accounting Officer) | February 25, 2025 | ||||||
| Kristina Truong | ||||||||
| /s/ Thurman John Rodgers | Chairman of the Board of Directors | February 25, 2025 | ||||||
| Thurman John Rodgers | ||||||||
| /s/ Betsy Atkins | Director | February 25, 2025 | ||||||
| Betsy Atkins | ||||||||
| /s/ Pegah Ebrahimi | Director | February 25, 2025 | ||||||
| Pegah Ebrahimi | ||||||||
| /s/ Bernard Gutmann | Director | February 25, 2025 | ||||||
| Bernard Gutmann | ||||||||
| /s/ Joseph Malchow | Director | February 25, 2025 | ||||||
| Joseph Malchow | ||||||||
| /s/ Gregory Reichow | Director | February 25, 2025 | ||||||
| Gregory Reichow | ||||||||
5